Ohri Manu has filed 8 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 5000 shares of Axil Brands, Inc. ($AXIL) on January 15, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | Axil Brands, Inc. | $AXIL | Ohri Manu | Director | A | Common Stock | 5000 | $0.00 | 25,001.0000 | 8,238,259 | 25.00% | 0.06% |
| Jan. 13, 2025 | Axil Brands, Inc. | $AXIL | Ohri Manu | Director | A | Common Stock | 5000 | $0.00 | 20,001.0000 | 8,194,882 | 33.33% | 0.06% |
| Feb. 14, 2024 | Axil Brands, Inc. | $AXIL | Ohri Manu | Director | A | Common Stock | 5000 | $0.00 | 15,001.0000 | 0 | 50.00% | 0.00% |
| Aug. 11, 2023 | GT Biopharma, Inc. | $GTBP | Ohri Manu | CFO & Secretary | A | Common Stock | 200000 | $0.29 | 550,000.0000 | 0 | 57.14% | 0.00% |
| Aug. 11, 2023 | GT Biopharma, Inc. | $GTBP | Ohri Manu | CFO & Secretary | J | Common Stock | 200000 | $0.29 | 350,000.0000 | 0 | 36.36% | 0.00% |
| Aug. 11, 2023 | GT Biopharma, Inc. | $GTBP | Ohri Manu | CFO & Secretary | J | Common Stock | 200000 | $0.29 | 350,000.0000 | 0 | 133.33% | 0.00% |
| April 6, 2023 | GT Biopharma, Inc. | $GTBP | Ohri Manu | CFO & Secretary | P | Common Stock | 50000 | $0.50 | 150,000.0000 | 0 | 50.00% | 0.00% |
| Jan. 27, 2023 | GT Biopharma, Inc. | $GTBP | Ohri Manu | Chief Financial Officer | A | Option to purchase Common Stock | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |